Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.
about
Fish oil for kidney transplant recipientsFish oil for kidney transplant recipientsGFR Estimating Equations and Liver DiseaseOutcomes of liver transplantation in patients with hepatorenal syndromeMetabolic and cardiovascular complications in the liver transplant recipientCardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should doPaneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury.Protection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice.Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation.The Role of e-NOS in Chronic Cholestasis-Induced Liver and Renal Injury in Rats: The Effect of N-Acetyl CysteinePredictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction.Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective reviewSerum sodium, renal function, and survival of patients with end-stage liver disease.Review article: current management of renal dysfunction in the cirrhotic patient.Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction.Acute kidney injury after hepatic ischemia and reperfusion injury in mice.Bioartificial liver systems: why, what, whither?Human heat shock protein 27-overexpressing mice are protected against acute kidney injury after hepatic ischemia and reperfusion.Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice.Updates on Hepato-Renal SyndromeA single center experience of combined liver kidney transplantation.Octreotide Attenuates Acute Kidney Injury after Hepatic Ischemia and Reperfusion by Enhancing Autophagy.The challenges of providing renal replacement therapy in decompensated liver cirrhosis.Early use of renal-sparing agents in liver transplantation: a closer look.Global consequences of liver ischemia/reperfusion injury.Renal dysfunction in cirrhosis is not just a vasomotor nephropathy.Do patient characteristics influence efficacy and renal outcomes in liver transplant patients receiving everolimus?An Attempt to Establish a Common Animal Model for Hepatorenal Fibrosis in Rats.Selective intrarenal human A1 adenosine receptor overexpression reduces acute liver and kidney injury after hepatic ischemia reperfusion in mice.Diabetes mellitus and increased postoperative risk of acute renal failure after hepatectomy for hepatocellular carcinoma: a nationwide population-based study.Ascites in hepatitis C liver transplant recipients frequently occurs in the absence of advanced fibrosis.Sphingosine-1-phosphate reduces hepatic ischaemia/reperfusion-induced acute kidney injury through attenuation of endothelial injury in mice.Polycystic liver and kidney disease: post-transplant kidney function in patients receiving pre-emptive kidney transplantation.Silibinin Improves TNF-α and M30 Expression and Histological Parameters in Rat Kidneys After Hepatic Ischemia/Reperfusion.Pediatric liver transplantation for fibropolycystic liver disease.Naloxone pretreatment prevents kidney injury after liver ischemia reperfusion injury.Picric acid capped silver nanoparticles as a probe for colorimetric sensing of creatinine in human blood and cerebrospinal fluid samples.Nebivolol Ameliorates Hepatic Ischemia/Reperfusion Injury on Liver But Not on Distant Organs.
P2860
Q24245378-B28FA58C-1C40-49F7-80A1-7AAD12A71EC6Q26470403-1E19D954-BEBC-4502-8187-A13997D2371CQ27024817-B2FB6064-D2E2-4B4D-A90E-9EB53519AAB6Q28068506-CCF0B335-2305-4B0A-9DAB-3B3990DAED1CQ28082243-01D52AF8-1236-4DEE-80A8-0FAFA8353D04Q33716191-116DF3FD-CECE-4D49-BA8A-CE96600CDD71Q33832522-C7D2DE6A-A589-48F0-B5DA-AEAF4AFFDE0AQ33890909-1A1D74FC-5B64-43FC-90FC-F5FD3A2D97CAQ34430282-38BD77AB-449D-4B2B-9FF9-DC4514ECCD75Q34561909-32E4FFD2-381B-46C0-88D0-1A871AE614D8Q34816170-D7229002-CECF-4C16-A0BA-07D3617FD72AQ34979807-CACA7AA2-CBFB-4E8F-A816-888CFAA900F6Q35988332-F2CD4417-9122-4378-8E5C-FDFB72368E12Q36090748-F07B67BB-5D93-4330-A2DB-14B38A4A36D6Q36709693-5539E64E-4E02-4901-9A0F-B37C530998A1Q37076990-DBB0F410-9CC8-4ACA-925A-9BAFEE7A9C42Q37202810-025D752C-E125-4275-B27E-650EF42C528DQ37417275-2107B99B-356C-4A68-AAF6-2A3FFE568151Q37480008-4D52B6B8-380C-466B-BD44-8E7CCE1C37E5Q37498513-18C10FC3-48C3-49E8-8B7A-1F757A5C452AQ37636489-C4E2AE34-D7E7-4520-BD92-5413F84AE77AQ37644366-9844D0D9-AA69-400E-9578-9B54DFF3B4E6Q37978059-E9395F11-1F5B-4E3D-BFA7-7F01F7190CCAQ38108593-2D941361-74F9-47B0-898B-06DB0297C859Q38209664-1A13EB6C-DA6B-4FCE-84F1-B3654089FB7FQ38258146-2E20B280-30FA-4699-9C4F-3C8610E3B3E9Q40158833-8877016D-43E5-4ECD-BA4C-448DCE51C1D1Q41395343-17569A45-E6CD-4229-ABC0-BC6594B3E60BQ43197104-CA0B1457-A3CA-445C-B767-BCED35F55D83Q44017561-0FE7FD5C-0023-4CFD-8E21-DB08BA38FFDCQ45983004-9E09E712-AB07-429F-89E2-B2113F57B506Q46009588-8AD3E9E4-BBF2-45A8-BEDF-25B227F177CFQ46826859-07C56E76-DCE1-4981-9FCF-0F309ED565CEQ50720323-997FF54D-DC2F-4458-BB36-AF929BB0C028Q50962163-D1D6E34A-31F5-48F4-95A8-F7C2C16DAB91Q53127548-410D0ED7-0A2C-47B9-BB03-D4566088DB44Q53304234-EBA1DE14-C3E0-4084-8E03-DBAA0E6F8E50Q53367845-9735CF42-8B0F-43D0-943B-4C1B7E5E6F98
P2860
Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Pathophysiology of renal disea ...... liver transplantation. Part I.
@ast
Pathophysiology of renal disea ...... liver transplantation. Part I.
@en
Pathophysiology of renal disea ...... liver transplantation. Part I.
@nl
type
label
Pathophysiology of renal disea ...... liver transplantation. Part I.
@ast
Pathophysiology of renal disea ...... liver transplantation. Part I.
@en
Pathophysiology of renal disea ...... liver transplantation. Part I.
@nl
prefLabel
Pathophysiology of renal disea ...... liver transplantation. Part I.
@ast
Pathophysiology of renal disea ...... liver transplantation. Part I.
@en
Pathophysiology of renal disea ...... liver transplantation. Part I.
@nl
P2093
P2860
P356
P1476
Pathophysiology of renal disea ...... liver transplantation. Part I.
@en
P2093
Alan H Wilkinson
Connie L Davis
Thomas A Gonwa
P2860
P304
P356
10.1053/JLTS.2002.31516
P577
2002-02-01T00:00:00Z